Seong-Bin Yang

发表

Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules

T. Kang, Ji-Hong Lim, Jooho Park, 2021, International journal of molecular sciences.

Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy

Jooho Park, Nipa Banik, Seong-Bin Yang, 2022, Pharmaceutics.

Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy

T. Kang, Jooho Park, Seong-Bin Yang, 2023, Pharmaceutics.

An amphiphilic material arginine-arginine-bile acid promotes α-synuclein amyloid formation.

J. Kardos, Sungsu Lim, Jaekwang Kim, 2023, Nanoscale.

Design of chimeric GLP-1A using oligomeric bile acids to utilize transporter-mediated endocytosis for oral delivery

Jin-woo Park, Y. Byun, J. Shim, 2023, Biomaterials Research.

Doxorubicin covalently conjugated heparin displays anti-cancer activity as a self-assembled nanoparticle with a low-anticoagulant effect.

Young Jun Kim, Jooho Park, Seong-Bin Yang, 2023, Carbohydrate polymers.

Design and Evaluation of a Carrier-Free Prodrug-Based Palmitic-DEVD-Doxorubicin Conjugate for Targeted Cancer Therapy.

Jooho Park, Young-Ho Lee, Seong-Bin Yang, 2023, Bioconjugate chemistry.

Design and development of novel self-assembled catechol-modified bile acid conjugates as pH-responsive apical sodium-dependent bile acid transporter targeting nanoparticles.

Jooho Park, S. Kweon, Seong-Bin Yang, 2024, Biomaterials.

Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect

S. Park, S. Kweon, Seong-Bin Yang, 2024, Nature communications.

Tumor targeting in situ aggregation of nanoparticle-to-nanoparticle strategy to simultaneously induce ferroptosis and immunogenic cell death using complementary heparin and protamine molecules

J. U. Choi, Ha Rin Kim, Seong-Bin Yang, 2024, Nano Today.